failed to achieve significancep = 0.07
While the METREO trial, which recruited only eosinophilic patients with the same criteria but using 100‐ and 300‐mg doses, failed to achieve significance (rate ratios 0.80, p = 0.07 and 0.86, p = 0.14, respectively).